BMSSC
MRNA icon

B. Metzler seel. Sohn & Co’s Moderna MRNA Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,688
Closed -$218K – 748
2025
Q1 		$218K Sell
7,688
-7,579
-50% -$269K ﹤0.01% 730
2024
Q4 		$635K Sell
15,267
-7,406
-33% -$354K 0.01% 618
2024
Q3 		$1.52M Buy
22,673
+4,229
+23% +$388K 0.02% 452
2024
Q2 		$2.19M Buy
18,444
+2,432
+15% +$308K 0.02% 362
2024
Q1 		$1.71M Buy
16,012
+1,653
+12% +$167K 0.02% 407
2023
Q4 		$1.43M Sell
14,359
-289
-2% -$24.3K 0.02% 433
2023
Q3 		$1.51M Buy
14,648
+6,242
+74% +$696K 0.02% 374
2023
Q2 		$1.02M Buy
8,406
+646
+8% +$86.2K 0.01% 486
2023
Q1 		$1.19M Sell
7,760
-948
-11% -$156K 0.02% 415
2022
Q4 		$1.56M Sell
8,708
-524
-6% -$85.7K 0.03% 352
2022
Q3 		$1.09M Buy
9,232
+698
+8% +$106K 0.02% 403
2022
Q2 		$1.22M Sell
8,534
-3,055
-26% -$437K 0.02% 392
2022
Q1 		$2M Sell
11,589
-300
-3% -$50.5K 0.03% 338
2021
Q4 		$2.99M Buy
11,889
+3,272
+38% +$957K 0.04% 259
2021
Q3 		$3.32M Buy
8,617
+415
+5% +$153K 0.05% 227
2021
Q2 		$1.93M Buy
8,202
+1,015
+14% +$181K 0.03% 304
2021
Q1 		$941K Buy
7,187
+3,214
+81% +$466K 0.02% 427
2020
Q4 		$442K Buy
+3,973
New +$402K 0.01% 549

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

B. Metzler seel. Sohn & Co's MRNA Position: Q2 2025 in Review

B. Metzler seel. Sohn & Co sold out of Moderna (MRNA) in Q2 2025, closing a stake of 7,688 shares — an estimated $218K sold.

B. Metzler seel. Sohn & Co first reported a position in MRNA in Q4 2020 and held it in 18 quarters. The position peaked at $3.32M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • B. Metzler seel. Sohn & Co reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 7,688 Moderna shares in Q2 2025, an estimated $218K.
  • B. Metzler seel. Sohn & Co first reported a position in Moderna in Q4 2020 and held it in 18 quarters.
  • B. Metzler seel. Sohn & Co's Moderna position peaked at $3.32M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2025, filed 11 Aug 2025.